Data from practice management software firm PriceMetrix show that advisers who increased their fee-based assets by more than 25% over the past three years saw revenue increase by an average of 47%.
As insurers put the brakes on variable annuity sales, an old rival is emerging as a potential powerhouse in the business.
With rates staying low, carriers have a dim three years on the horizon
With life expectancies rising, fixed income investments won't make savings last longer
Set up the company's first Las Vegas office; two other teams exit the herd as well
Low-ball valuation by Morgan Stanley doesn't inspire great confidence in future of big brokerage business
Finra said it is considering an exemption for a controversial fee it charges for existing members that make material changes to their firms
Foundations can't cover rising tab of grant programs, say Cornell, MIT; squeeze is on
Bond king says property, commodities a better bet for protecting purchasing power
A new report says advisers are getting false hopes from the recent hype about large RIA deals.
Eduardo Queen spent seven years at New York-based wirehouse
Citi says MSSB is worth $22B. Morgan Stanley says it's more like $9B. So who's right?
Midsize advisers who haven't completed their switch to state registration from the SEC could have their registrations withdrawn — possibly by the end of the year.
Because many complex financial products have the potential for sudden and/or severe losses of principal, it is imperative that firms recommending these products document a thorough “reasonable basis” suitability analysis.
Investment advisers at large mutual fund companies and other financial institutions often operate with conflicts of interest, John Bogle, founder and former chief executive of The Vanguard Group Inc., told Securities and Exchange Commission Chairman Mary Schapiro on Tuesday.
Income enhancement still the biggest draw of VAs, study finds
Meg Green, who left Royal Alliance for Sterne Agee, says bosses at former parent company AIG 'didn't understand culture'.
Bachus bill denounced at TD Ameritrade conference; momentum shifting?
